Pemafibrate for Symptomatic ICAS RCT
Pemafibrate for Symptomatic ICAS RCT
Recruiting · NCT07562178 · Registry updated 2026-08-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Pemafibrate for Symptomatic ICAS RCT | Dyslipidemias, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, hyperlipidemia, hypertriglyceridemia, metabolic disease, nervous system disorder, stroke disorder, vascular disorder | Recruiting | Not applicable | 2026-08-03 | NCT07562178 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Kowa Company, Ltd. | 3 |
| Tokyo Women's Medical University | 6 |
37 results · Page 1 of 2
Research sites
Swipe the table sideways for more columns.